九強生物(300406.SZ)擬將2019年度審計機構由瑞華所變更為致同所
格隆匯11月7日丨九強生物(300406.SZ)公佈,公司於2019年11月7日召開第三屆董事會第二十四次會議、第三屆監事會第二十二次會議,審議通過了《關於變更會計師事務所的議案》,公司擬將2019年度審計機構由瑞華會計師事務所(特殊普通合夥)(“瑞華所”)變更為致同會計師事務所(特殊普通合夥)(“致同所”),該事項尚需提交公司股東大會審議。
公司原審計機構瑞華所在執業過程中,堅持獨立審計原則,客觀、公正、公允地反映公司財務狀況,切實履行審計機構應盡的職責,從專業的角度維護了公司及股東的合法權益。鑑於瑞華所已連續多年為公司提供審計服務,為保持公司審計工作的獨立性、客觀性和公允性,同時根據公司經營發展需要,公司擬更換會計師事務所。經公司董事會審計委員會提議,公司擬聘任致同所為公司2019年度審計機構,並提請股東大會授權公司經營管理層根據2019年度審計的具體工作量及市場價格與審計機構協商確定2019年度財務審計費用。
公司已就變更會計師事務所事項與瑞華所進行了事先溝通,瑞華所明確知悉本事項並確認無異議。瑞華所在為公司提供審計服務期間,勤勉、盡責、切實履行了審計機構應盡的職責,公司對瑞華所多年來的辛勤工作表示誠摯的感謝!
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.